BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Intestine
,
Neocentromeres
,
Quercetin
,
rs2230926
,
IGF1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
intrinsic apoptotic signaling pathway by p53 class mediator
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Oral mucosa
Kidney cortex
Dorsal root ganglia
Amygdala
Stomach cardiac
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Flaviviridae
Vesicular stomatitis Indiana virus disease
Alpha-1-antitrypsin deficiency
Injury of eye region
Listeriosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
A 443654
CGP 60474
flavopiridol
OTS-167
Glesatinib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR30B
DIDO1
POLH
RPS6
CAMK1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Follicular fluid miRNA profiles during the development of the oocyte
Carotid arteries from atherogenic ApoE knockout mice with carotid artery injury
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Kidney epithelial HA1E.311 cells with CRISPR targeted gene knockouts
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for intrinsic apoptotic signaling pathway by p53 class mediator
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ